Your browser doesn't support javascript.
loading
Validation of the OPEN-CLEAN Chronic Total Occlusion Percutaneous Coronary Intervention Perforation Score in a Multicenter Registry.
Simsek, Bahadir; Carlino, Mauro; Ojeda, Soledad; Pan, Manuel; Rinfret, Stephane; Vemmou, Evangelia; Kostantinis, Spyridon; Nikolakopoulos, Ilias; Karacsonyi, Judit; Quadros, Alexandre S; Dens, Joseph A; Abi Rafeh, Nidal; Agostoni, Pierfrancesco; Alaswad, Khaldoon; Avran, Alexandre; Belli, Karlyse C; Choi, James W; Elguindy, Ahmed; Jaffer, Farouc A; Doshi, Darshan; Karmpaliotis, Dimitri; Khatri, Jaikirshan J; Khelimskii, Dmitrii; Knaapen, Paul; La Manna, Alessio; Krestyaninov, Oleg; Lamelas, Pablo; Padilla, Lucio; de Oliveira, Pedro Piccaro; Spratt, James C; Tanabe, Masaki; Walsh, Simon; Goktekin, Omer; Gorgulu, Sevket; Mastrodemos, Olga C; Allana, Salman; Rangan, Bavana V; Kearney, Kathleen E; Lombardi, William L; Grantham, J Aaron; Hirai, Taishi; Brilakis, Emmanouil S; Azzalini, Lorenzo.
Affiliation
  • Simsek B; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota.
  • Carlino M; Interventional Cardiology Division, Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy.
  • Ojeda S; Division of Interventional Cardiology, Reina Sofia Hospital, University of Cordoba, Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC), Cordoba, Spain.
  • Pan M; Division of Interventional Cardiology, Reina Sofia Hospital, University of Cordoba, Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC), Cordoba, Spain.
  • Rinfret S; Emory Heart and Vascular Center, Emory University School of Medicine, Atlanta, Georgia.
  • Vemmou E; Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
  • Kostantinis S; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota.
  • Nikolakopoulos I; Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
  • Karacsonyi J; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota.
  • Quadros AS; Instituto de Cardiologia do Rio Grande do Sul, Porto Alegre, Brazil.
  • Dens JA; Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium.
  • Abi Rafeh N; North Oaks Health System, Hammond, Louisiana.
  • Agostoni P; Hartcentrum, Ziekenhuis Netwerk Antwerpen Middelheim, Antwerp, Belgium.
  • Alaswad K; Henry Ford Health System, Detroit, Michigan.
  • Avran A; Department of Interventional Cardiology, Clinique Pasteur, Essey-lès-Nancy, France.
  • Belli KC; Instituto de Cardiologia do Rio Grande do Sul, Porto Alegre, Brazil.
  • Choi JW; Presbyterian Hospital, Dallas, Texas.
  • Elguindy A; Magdi Yacoub Heart Foundation, Cairo, Egypt.
  • Jaffer FA; Massachusetts General Hospital, Boston, Massachusetts.
  • Doshi D; Massachusetts General Hospital, Boston, Massachusetts.
  • Karmpaliotis D; Morristown Medical Center, Morristown, New Jersey.
  • Khatri JJ; Cleveland Clinic Foundation, Cleveland, Ohio.
  • Khelimskii D; Meshalkin Siberian Federal Biomedical Research Center, Ministry of Health of Russian Federation, Novosibirsk, Russian Federation.
  • Knaapen P; Department of Cardiology, VU University Medical Center, Amsterdam, The Netherlands.
  • La Manna A; University of Catania, Catania, Italy.
  • Krestyaninov O; Meshalkin Siberian Federal Biomedical Research Center, Ministry of Health of Russian Federation, Novosibirsk, Russian Federation.
  • Lamelas P; Instituto Cardiovascularde Buenos Aires, Buenos Aires, Argentina.
  • Padilla L; Instituto Cardiovascularde Buenos Aires, Buenos Aires, Argentina.
  • de Oliveira PP; Fundação Universitária de Cardiologia, Porto Alegre, Brazil.
  • Spratt JC; St. George's University Healthcare NHS Trust, London, United Kingdom.
  • Tanabe M; Department of Cardiology, Nozaki Tokushukai Hospital, Osaka, Japan.
  • Walsh S; Belfast Health, Belfast, United Kingdom.
  • Goktekin O; Memorial Bahcelievler Hospital, Istanbul, Turkey.
  • Gorgulu S; Acibadem Kocaeli Hospital, Kocaeli, Turkey.
  • Mastrodemos OC; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota.
  • Allana S; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota.
  • Rangan BV; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota.
  • Kearney KE; Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington.
  • Lombardi WL; Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington.
  • Grantham JA; Saint Luke's Mid-America Heart Institute, Kansas City, Missouri.
  • Hirai T; University of Missouri-Kansas City, Kansas City, Missouri.
  • Brilakis ES; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota.
  • Azzalini L; Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington. Electronic address: azzalini@uw.edu.
Am J Cardiol ; 188: 30-35, 2023 02 01.
Article in En | MEDLINE | ID: mdl-36462272
Coronary artery perforation is one of the most common and feared complications of chronic total occlusion (CTO) percutaneous coronary intervention (PCI). We evaluated the utility of the recently presented OPEN-CLEAN (Coronary artery bypass graft, Length of occlusion, Ejection fraction, Age, calcificatioN) perforation score in an independent multicenter CTO PCI dataset. Of the 2,270 patients who underwent CTO PCI at 7 centers, 150 (6.6%) suffered coronary artery perforation. Patients with perforations were older (69 ± 10 vs 65 ± 10, p <0.001), more likely to be women (89% vs 82%, p = 0.010), more likely to have history of previous coronary artery bypass graft (38% vs 20%, p <0.001), and unfavorable angiographic characteristics such as blunt stump (64% vs 42%, p <0.001), proximal cap ambiguity (51% vs 33%, p <0.001), and moderate-severe calcification (57% vs 43%, p = 0.001). Technical success was lower in patients with perforations (69% vs 85%, p <0.001). The area under the receiver operating characteristic curve of the OPEN-CLEAN perforation risk model was 0.74 (95% confidence interval 0.68 to 0.79), with good calibration (Hosmer-Lemeshow p = 0.72). We found that the CTO PCI perforation risk increased with higher OPEN-CLEAN scores: 3.5% (score 0 to 1), 3.1% (score 2), 5.3% (score 3), 7.1% (score 4), 11.5% (score 5), 19.8% (score 6 to 7). In conclusion, given its good performance and ease of preprocedural calculation, the OPEN-CLEAN perforation score appears to be useful for quantifying the perforation risk for patients who underwent CTO PCI.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Occlusion / Vascular System Injuries / Percutaneous Coronary Intervention Type of study: Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Am J Cardiol Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Occlusion / Vascular System Injuries / Percutaneous Coronary Intervention Type of study: Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Am J Cardiol Year: 2023 Type: Article